Bayesian BE Assessment [Study As­sess­ment]

posted by Ben – 2017-03-13 19:55 (2980 d 08:45 ago) – Posting: # 17150
Views: 3,516

Dear All,

In times where Bayesian techniques come more often I was wondering about BE trials and therefore my question: Has anyone of you evaluated a BE trial using Bayesian techniques? I guess in a confirmatory setting the answer of our regulators is clear: not acceptable. Or not? Ok, maybe as a secondary analysis. What was the feedback from the agency? What kind of prior did you use? (interesting would of course be a case which is not non-informative like in [1, Section 5.9])

Experiences or ideas are much appreciated.

Thanks,
Ben.

[1] Patterson, Jones. Bioequivalence and Statistics in Clinical Pharmacology. Chapman & Hall/CRC, Boca Raton 2006.

Complete thread:

UA Flag
Activity
 Admin contact
23,424 posts in 4,927 threads, 1,668 registered users;
127 visitors (0 registered, 127 guests [including 6 identified bots]).
Forum time: 05:41 CEST (Europe/Vienna)

Lack of clarity is always a sign of dishonesty.    Celia Green

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5